Rajendra Sanghavi Sr. Consulting Clinician & Chairman – Medical Committee

Rajendra Sanghavi

Sr. Consulting Clinician & Chairman – Medical Committee

Indian Drug Manufacturers’ Association (IDMA)

102, Poonam Chambers,’A’ Wing, 1st Floor, Dr. A. B. Road, Worli, Mumbai – 400 018

https://www.idma-assn.org/

Indian Drug Manufacturers’ Association (IDMA) was formed in 1961

Successfully completed 55 glorious years of providing safe efficacious affordable quality medicines, not only to our people, but people all over the world.

Membership of over 1000 wholly-Indian large, medium and small companies and State Boards (SB) in Gujarat, Himachal Pradesh & Uttaranchal, Haryana, Tamil Nadu, West Bengal, Madhya Pradesh, Telengana and Karnataka

The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent during 2005-16 with the market increasing from US$ 6 billion in 2005 to US$ 36.7 billion in 2016 and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020.

Members’ Indian Market share – about 75% in formulations and about 85% in APIs

In FY16, India exported pharmaceutical products worth US$ 16.89 billion, with the number expected to reach US$ 40 billion by 2020.

Members’ Export Record – about 75% of India’s total drugs & pharma exports

Indian pharma companies spend 8-11 per cent of their total turnover on R&D